• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

PDRP violations

anonymous

Guest
I am a medical writer looking for someone willing to go on the record regarding violations of PDRP (physician data restriction program) by drug manufacturers. That is, I'm interested knowing about prescription info of PDRP doctors being made available to drug reps.

I look forward to hearing from you.

You can contact me at: medwriter963@gmail.com.

Many thanks!